Latest Product Innovation News

ikeGPS Group Limited reported a 33% surge in subscription revenue to NZ$19.2 million for FY26, driven by AI-powered product innovation and expanding adoption among North American utilities. The company achieved positive underlying EBITDA in March and ended the year with NZ$33 million cash and no debt.

Collins Foods delivered record FY26 revenue and underlying profit, declaring a 15c fully franked final dividend while exiting Taco Bell to sharpen focus on KFC expansion in Australia and Europe.

Turners Automotive Group posted a record $63.2 million normalised NPBT for FY26, beating guidance and declaring a 14% higher dividend as it accelerates branch expansion and ecosystem integration.

SunRice reported a 4% rise in net profit after tax for FY26 to $73.3 million, maintaining an 8% EBITDA margin despite a 2.5% revenue decline. The company declared a record fully franked dividend of 70 cents per share but expects FY27 profit to fall amid a smaller Australian rice crop.

The Calmer Co. has won Coles' approval for its innovative Fiji Kava® FZZR™ product, extending its Australian supermarket reach while gearing up for a broader U.S. retail rollout supported by a key brokerage partnership.

PointsBet’s FY26 nine-month report reflects a transitional period marked by MIXI’s 66.4% takeover, a slight revenue dip to AUD 186.6 million, and a near breakeven normalised EBITDA. Australian revenue softened by 4%, while Canada grew 13% driven by iGaming momentum.

CleanSpace's AGILE respirator has achieved AS/NZS 17420.2:2021 certification, paving the way for commercialisation in Australia and New Zealand alongside its recent European approval.

NobleOak Life Limited boosted its Embedded Value by 9% to $2.34 per share as of December 2025, driven by strong premium growth and market share gains. The insurer exceeded its FY26 in-force premium guidance with a 16% increase to $538 million.

Microba Life Sciences is targeting a $6 million capital raise through a $1 million Securities Purchase Plan and a $5 million Placement, both subject to shareholder approval. The funds aim to accelerate diagnostics growth and develop a new testing product.

Beamtree Holdings has appointed Gareth Pye as its new CEO, aiming to pivot towards stronger operational execution and commercial focus amid ongoing international expansion.

Microba Life Sciences secures $5 million in a placement led by Sonic Healthcare to fund its push towards cashflow break-even by 2027, backed by strong diagnostic sales and AI-driven efficiencies.

CleanSpace Holdings has achieved a major regulatory milestone with European EN 12941 certification for its new AGILE loose-fitting PAPR, positioning the company for growth in its largest market and preparing for imminent Australian approval.